FDA unveils drug compounding rules

07/2/2014 | Hill, The

Regulations of compounding pharmacies were released Tuesday by the FDA to establish manufacturing standards and update the list of drugs considered too dangerous to be changed. Noncompliant compounders could face seizures and prosecution. The regulations outline a risk-based approach, but action can be taken without the identification of a safety issue.

View Full Article in:

Hill, The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
President/Chief Executive Officer
MedCost
Winston-Salem, NC
Consumer Directed Health Plan (CDH) Product Offering Manager
Blue Cross Blue Shield MA
Quincy, MA
Director, Payer Marketing
Avalere Health
Washington, DC
Actuary
Meridian Health Plan
Detroit, MI
Chief Medical Officer, Texas Children's Health Plan
Cejka Executive Search for Texas Childre's Health Plan
Houston, TX